The extracellular matrix at a glance

Journal of Cell Science

Volumn 123, Issue 24, 2010, Pages 4195-4200

  Frantz, Christian ^a   Stewart, Kathleen M ^a   Weaver, Valerie M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRONECTIN; PROTEOGLYCAN;

AGING; EPITHELIUM; EXTRACELLULAR MATRIX; FIBROSIS; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; TUMOR;

ANIMALS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; HOMEOSTASIS; HUMANS; NEOPLASMS;

EID: 78649737455     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.023820     Document Type: Review

References (102)

1. Akintola, A. D., Crislip, Z. L., Catania, J. M., Chen, G., Zimmer, W. E., Burghardt, R. C. and Parrish, A. R. (2008). Promoter methylation is associated with the age-dependent loss of N-cadherin in the rat kidney. Am. J. Physiol. Renal Physiol. 294, F170-F176.
2. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. (2007). Molecular Biology of the Cell. London: Garland Science.
3. Ayres, C. E., Jha, B. S., Sell, S. A., Bowlin, G. L. and Simpson, D. G. (2009). Nanotechnology in the design of soft tissue scaffolds: innovations in structure and function. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2, 20-34.
4. Badylak, S. F. (2007). The extracellular matrix as a biologic scaffold material. Biomaterials 28, 3587-3593.
5. Barsky, S. H. and Karlin, N. J. (2005). Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J. Mammary Gland Biol. Neoplasia 10, 249-260.
6. Bissell, M. J. and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54.
7. Blombäck, B. and Bark, N. (2004). Fibrinopeptides and fibrin gel structure. Biophys. Chem. 112, 147-151.
8. Bolognia, J. L. (1995). Aging skin. Am. J. Med. 98, 99S-103S.
9. Bosman, F. T. and Stamenkovic, I. (2003). Functional structure and composition of the extracellular matrix. J. Pathol. 200, 423-428.
10. Butcher, D. T., Alliston, T. and Weaver, V. M. (2009). A tense situation: forcing tumour progression. Nat. Rev. Cancer 9, 108-122.
11. Callaghan, T. M. and Wilhelm, K. P. (2008). A review of ageing and an examination of clinical methods in the assessment of ageing skin. Part 2, Clinical perspectives and clinical methods in the evaluation of ageing skin. Int. J. Cosmet. Sci. 30, 323-332.
12. Calleja-Agius, J., Muscat-Baron, Y. and Brincat, M. P. (2007). Skin ageing. Menopause Int. 13, 60-64.
13. Campisi, J. and d'Adda di Fagagna, F. (2007). Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740.
14. Clark, R. A. (2001). Fibrin and wound healing. Ann. NY Acad. Sci. 936, 355-367.
15. Coppe, J. P., Desprez, P. Y., Krtolica, A. and Campisi, J. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118.
16. Cruz-Munoz, W. and Khokha, R. (2008). The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit. Rev. Clin. Lab. Sci. 45, 291-338.
17. De Wever, O., Demetter, P., Mareel, M. and Bracke, M. (2008). Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 123, 2229-2238.
18. Desmouliere, A., Guyot, C. and Gabbiani, G. (2004). The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int. J. Dev. Biol. 48, 509-517. (Pubitemid 39360401)
19. Dutta, R. C. and Dutta, A. K. (2009). Cell-interactive 3D-scaffold; advances and applications. Biotechnol. Adv. 27, 334-339.
20. Egeblad, M., Rasch, M. G. and Weaver, V. M. (2010). Dynamic interplay between the collagen scaffold and tumor evolution. Curr. Opin. Cell Biol. 22, 697-706.
21. Ehrbar, M., Rizzi, S. C., Schoenmakers, R. G., Miguel, B. S., Hubbell, J. A., Weber, F. E. and Lutolf, M. P. (2007). Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions. Biomacromolecules 8, 3000-3007.
22. Erler, J. T. and Weaver, V. M. (2009). Three-dimensional context regulation of metastasis. Clin. Exp. Metastasis 26, 35-49.
23. Franklin, M. E., Jr, Gonzalez, J. J., Jr, Michaelson, R. P., Glass, J. L. and Chock, D. A. (2002). Preliminary experience with new bioactive prosthetic material for repair of hernias in infected fields. Hernia 6, 171-174.
24. Freund, A., Orjalo, A. V., Desprez, P. Y. and Campisi, J. (2010). Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 16, 238-246.
25. Friedl, A. (2010). Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions. Semin. Cell Dev. Biol. 21, 66-71.
26. Friedland, J. C., Lee, M. H. and Boettiger, D. (2009). Mechanically activated integrin switch controls alpha5beta1 function. Science 323, 642-644.
27. Friess, W. (1998). Collagen-biomaterial for drug delivery. Eur. J. Pharm. Biopharm. 45, 113-136.
28. Goldoni, S. and Iozzo, R. V. (2008). Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int. J. Cancer 123, 2473-2479.
29. Gordon, M. K. and Hahn, R. A. (2010). Collagens. Cell Tissue Res. 339, 247-257.
30. Gudjonsson, T., Ronnov-Jessen, L., Villadsen, R., Rank, F., Bissell, M. J. and Petersen, O. W. (2002). Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 115, 39-50.
31. Harburger, D. S. and Calderwood, D. A. (2009). Integrin signalling at a glance. J. Cell Sci. 122, 159-163.
32. Harvey, S. J. and Miner, J. H. (2008). Revisiting the glomerular charge barrier in the molecular era. Curr. Opin. Nephrol. Hypertens. 17, 393-398.
33. Hauser, C. A. and Zhang, S. (2010). Designer self-assembling peptide nanofiber biological materials. Chem. Soc. Rev. 39, 2780-2790.
34. Humphries, J. D., Byron, A. and Humphries, M. J. (2006). Integrin ligands at a glance. J. Cell Sci. 119, 3901-3903.
35. Hynes, R. O. (2009). The extracellular matrix: not just pretty fibrils. Science 326, 1216-1219.
36. Iozzo, R. V. and Murdoch, A. D. (1996). Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10, 598-614.
37. Iozzo, R. V., Zoeller, J. J. and Nystrom, A. (2009). Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Mol. Cells 27, 503-513.
38. Jarvelainen, H., Sainio, A., Koulu, M., Wight, T. N. and Penttinen, R. (2009). Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol. Rev. 61, 198-223.
39. Johnson, K. R., Leight, J. L. and Weaver, V. M. (2007). Demystifying the effects of a three-dimensional microenvironment in tissue morphogenesis. Methods Cell Biol. 83, 547-583.
40. Kass, L., Erler, J. T., Dembo, M. and Weaver, V. M. (2007). Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int. J. Biochem. Cell Biol. 39, 1987-1994.
41. Kessenbrock, K., Plaks, V. and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
42. Kim, D. H., Lipke, E. A., Kim, P., Cheong, R., Thompson, S., Delannoy, M., Suh, K. Y., Tung, L. and Levchenko, A. (2010). Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc. Natl. Acad. Sci. USA 107, 565-570.
43. Kisseleva, T. and Brenner, D. A. (2008). Mechanisms of fibrogenesis. Exp. Biol. Med. (Maywood) 233, 109-122.
44. Kleinman, H. K. and Martin, G. R. (2005). Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 15, 378-386.
45. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W. and Martin, G. R. (1986). Basement membrane complexes with biological activity. Biochemistry 25, 312-318.
46. Kuschel, C., Steuer, H., Maurer, A. N., Kanzok, B., Stoop, R. and Angres, B. (2006). Cell adhesion profiling using extracellular matrix protein microarrays. Biotechniques 40, 523-531.
47. LeBleu, V. S., Macdonald, B. and Kalluri, R. (2007). Structure and function of basement membranes. Exp. Biol. Med. (Maywood) 232, 1121-1129.
48. Leiss, M., Beckmann, K., Giros, A., Costell, M. and Fassler, R. (2008). The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr. Opin. Cell Biol. 20, 502-507.
49. Leitinger, B. and Hohenester, E. (2007). Mammalian collagen receptors. Matrix Biol. 26, 146-155.
50. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F., Csiszar, K., Giaccia, A., Weninger, W. et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906.
51. Lucero, H. A. and Kagan, H. M. (2006). Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell. Mol. Life Sci. 63, 2304-2316.
52. Lutolf, M. P. and Hubbell, J. A. (2005). Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47-55.
53. Lutolf, M. P., Gilbert, P. M. and Blau, H. M. (2009). Designing materials to direct stem-cell fate. Nature 462, 433-441.
54. Macchiarini, P., Jungebluth, P., Go, T., Asnaghi, M. A., Rees, L. E., Cogan, T. A., Dodson, A., Martorell, J., Bellini, S., Parnigotto, P. P. et al. (2008). Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023-2030.
55. Macri, L., Silverstein, D. and Clark, R. A. (2007). Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv. Drug Deliv. Rev. 59, 1366-1381.
56. Mao, Y. and Schwarzbauer, J. E. (2005). Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 24, 389-399.
57. McCullen, S. D., Ramaswamy, S., Clarke, L. I. and Gorga, R. E. (2009). Nanofibrous composites for tissue engineering applications. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 369-390.
58. Morita, H., Yoshimura, A., Inui, K., Ideura, T., Watanabe, H., Wang, L., Soininen, R. and Tryggvason, K. (2005). Heparan sulfate of perlecan is involved in glomerular filtration. J. Am. Soc. Nephrol. 16, 1703-1710. (Pubitemid 41716476)
59. Mott, J. D. and Werb, Z. (2004). Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564.
60. Murakami, M., Elfenbein, A. and Simons, M. (2008). Non-canonical fibroblast growth factor signalling in angiogenesis. Cardiovasc. Res. 78, 223-231. (Pubitemid 351556091)
61. Myllyharju, J. and Kivirikko, K. I. (2004). Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 20, 33-43. (Pubitemid 38032818)
62. Nomura, Y. (2006). Structural change in decorin with skin aging. Connect. Tissue Res. 47, 249-255. (Pubitemid 44803792)
63. Oehrl, W. and Panayotou, G. (2008). Modulation of growth factor action by the extracellular matrix. Connect. Tissue Res. 49, 145-148.
64. Pankov, R. and Yamada, K. M. (2002). Fibronectin at a glance. J. Cell Sci. 115, 3861-3863.
65. Paszek, M. J. and Weaver, V. M. (2004). The tension mounts: mechanics meets morphogenesis and malignancy. J. Mammary Gland Biol. Neoplasia 9, 325-342.
66. Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D. et al. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254.
67. Payne, S. L., Hendrix, M. J. and Kirschmann, D. A. (2007). Paradoxical roles for lysyl oxidases in cancer-a prospect. J. Cell Biochem. 101, 1338-1354.
68. Pelham, R. J., Jr and Wang, Y. (1997). Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc. Natl. Acad. Sci. USA 94, 13661-13665.
69. Provenzano, P. P., Eliceiri, K. W. and Keely, P. J. (2009). Shining new light on 3D cell motility and the metastatic process. Trends Cell. Biol. 19, 638-648.
70. Robins, S. P. (2007). Biochemistry and functional significance of collagen cross-linking. Biochem. Soc. Trans. 35, 849-852.
71. Rodriguez, C., Rodriguez-Sinovas, A. and Martinez-Gonzalez, J. (2008). Lysyl oxidase as a potential therapeutic target. Drug News Perspect. 21, 218-224.
72. Ronnov-Jessen, L., Petersen, O. W. and Bissell, M. J. (1996). Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76, 69-125. (Pubitemid 26048279)
73. Rosso, F., Marino, G., Giordano, A., Barbarisi, M., Parmeggiani, D. and Barbarisi, A. (2005). Smart materials as scaffolds for tissue engineering. J. Cell Physiol. 203, 465-470. (Pubitemid 40629007)
74. Rozario, T. and DeSimone, D. W. (2010). The extracellular matrix in development and morphogenesis: a dynamic view. Dev. Biol. 341, 126-140.
75. Schaefer, L. and Iozzo, R. V. (2008). Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J. Biol. Chem. 283, 21305-21309.
76. Schaefer, L. and Schaefer, R. M. (2010). Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res. 339, 237-246.
77. Schafer, M. and Werner, S. (2008). Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol. 9, 628-638.
78. Schmidt, S. and Friedl, P. (2010). Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms. Cell Tissue Res. 339, 83-92.
79. Schultz, G. S. and Wysocki, A. (2009). Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 17, 153-162.
80. Scott, J. E. (2003). Elasticity in extracellular matrix 'shape modules' of tendon, cartilage, etc. A sliding proteoglycan-filament model. J. Physiol. 553, 335-343.
81. Serban, M. A. and Prestwich, G. D. (2008). Modular extracellular matrices: solutions for the puzzle. Methods 45, 93-98.
82. Shaikh, F. M., Callanan, A., Kavanagh, E. G., Burke, P. E., Grace, P. A. and McGloughlin, T. M. (2008). Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188, 333-346.
83. Sieminski, A. L., Semino, C. E., Gong, H. and Kamm, R. D. (2008). Primary sequence of ionic self-assembling peptide gels affects endothelial cell adhesion and capillary morphogenesis. J. Biomed. Mater. Res. A 87, 494-504.
84. Smith, I. O., Liu, X. H., Smith, L. A. and Ma, P. X. (2009). Nanostructured polymer scaffolds for tissue engineering and regenerative medicine. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 226-236.
85. Smith, L. A. and Ma, P. X. (2004). Nano-fibrous scaffolds for tissue engineering. Colloids Surf. B Biointerfaces 39, 125-131.
86. Smith, M. L., Gourdon, D., Little, W. C., Kubow, K. E., Eguiluz, R. A., Luna-Morris, S. and Vogel, V. (2007). Force-induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol. 5, e268.
87. Sprenger, C. C., Plymate, S. R. and Reed, M. J. (2008). Extracellular influences on tumour angiogenesis in the aged host. Br. J. Cancer 98, 250-255.
88. Szauter, K. M., Cao, T., Boyd, C. D. and Csiszar, K. (2005). Lysyl oxidase in development, aging and pathologies of the skin. Pathol. Biol. 53, 448-456. (Pubitemid 41112081)
89. Tan, T. T. and Coussens, L. M. (2007). Humoral immunity, inflammation and cancer. Curr. Opin. Immunol. 19, 209-216.
90. Trebaul, A., Chan, E. K. and Midwood, K. S. (2007). Regulation of fibroblast migration by tenascin-C. Biochem. Soc. Trans. 35, 695-697.
91. Tsang, K. Y., Cheung, M. C., Chan, D. and Cheah, K. S. (2010). The developmental roles of the extracellular matrix: beyond structure to regulation. Cell Tissue Res. 339, 93-110.
92. Tucker, R. P. and Chiquet-Ehrismann, R. (2009). The regulation of tenascin expression by tissue microenvironments. Biochim. Biophys. Acta 1793, 888-892.
93. Ulijn, R. V. and Smith, A. M. (2008). Designing peptide based nanomaterials. Chem. Soc. Rev. 37, 664-675.
94. Untergasser, G., Madersbacher, S. and Berger, P. (2005). Benign prostatic hyperplasia: age-related tissue-remodeling. Exp. Gerontol. 40, 121-128.
95. Vakonakis, I. and Campbell, I. D. (2007). Extracellular matrix: from atomic resolution to ultrastructure. Curr. Opin. Cell Biol. 19, 578-583.
96. Velnar, T., Bailey, T. and Smrkolj, V. (2009). The wound healing process: an overview of the cellular and molecular mechanisms. J. Int. Med. Res. 37, 1528-1542.
97. Wipff, P. J., Rifkin, D. B., Meister, J. J. and Hinz, B. (2007). Myofibroblast contraction activates latent TGFbeta1 from the extracellular matrix. J. Cell Biol. 179, 1311-1323.
98. Wise, S. G. and Weiss, A. S. (2009). Tropoelastin. Int. J. Biochem. Cell Biol. 41, 494-497.
99. Xian, X., Gopal, S. and Couchman, J. R. (2010). Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res. 339, 31-46.
100. Xu, J., Lamouille, S. and Derynck, R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172.
101. Zhang, X., Reagan, M. R. and Kaplan, D. L. (2009). Electrospun silk biomaterial scaffolds for regenerative medicine. Adv. Drug Deliv. Rev. 61, 988-1006.
102. Zisch, A. H., Lutolf, M. P. and Hubbell, J. A. (2003). Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc. Pathol. 12, 295-310.